文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

帕金森病 A30P/A53T 双突变α-突触核蛋白基因敲入小鼠模型中的年龄依赖性神经退行性变和神经炎症。

Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.

机构信息

Department of Neurology, University Hospital of Würzburg, Josef-Schneider-Straße 11, 97080 Würzburg, Germany.

Department of Neurology, University Hospital of Würzburg, Josef-Schneider-Straße 11, 97080 Würzburg, Germany.

出版信息

Neurobiol Dis. 2022 Sep;171:105798. doi: 10.1016/j.nbd.2022.105798. Epub 2022 Jun 21.


DOI:10.1016/j.nbd.2022.105798
PMID:35750147
Abstract

The pathogenesis of Parkinson's disease (PD) is closely interwoven with the process of aging. Moreover, increasing evidence from human postmortem studies and from animal models for PD point towards inflammation as an additional factor in disease development. We here assessed the impact of aging and inflammation on dopaminergic neurodegeneration in the hmα-SYN-39 mouse model of PD that carries the human, A30P/A53T double-mutated α-synuclein gene. At 2-3 months of age, no significant differences were observed comparing dopaminergic neuron numbers of the substantia nigra (SN) pars compacta of hmα-SYN-39 mice with wildtype controls. At an age of 16-17 months, however, hmα-SYN-39 mice revealed a significant loss of dopaminergic SN neurons, of dopaminergic terminals in the striatum as well as a reduction of striatal dopamine levels compared to young, 2-3 months transgenic mice and compared to 16-17 months old wildtype littermates. A significant age-related correlation of infiltrating CD4 and CD8 T cell numbers with dopaminergic terminal loss of the striatum was found in hmα-SYN-39 mice, but not in wildtype controls. In the striatum of 16-17 months old wildtype mice a slightly elevated CD8 T cell count and CD11b microglia cell count was observed compared to younger aged mice. Additional analyses of neuroinflammation in the nigrostriatal tract of wildtype mice did not yield any significant age-dependent changes of CD4, CD8 T cell and B220 B cell numbers, respectively. In contrast, a significant age-dependent increase of CD8 T cells, GFAP astrocytes as well as a pronounced increase of CD11b microglia numbers were observed in the SN of hmα-SYN-39 mice pointing towards a neuroinflammatory processes in this genetic mouse model for PD. The findings in the hmα-SYN-39 mouse model strengthen the evidence that T cell and glial cell responses are involved in the age-related neurodegeneration in PD. The slow and age-dependent progression of neurodegeneration and neuroinflammation in the hmα-SYN-39 PD rodent model underlines its translational value and makes it suitable for studying anti-inflammatory therapies.

摘要

帕金森病 (PD) 的发病机制与衰老过程密切相关。此外,越来越多的人类尸检研究和 PD 动物模型的证据表明,炎症是疾病发展的另一个因素。我们在这里评估了衰老和炎症对携带人类 A30P/A53T 双突变α-突触核蛋白基因的 hmα-SYN-39 PD 小鼠模型中多巴胺能神经元变性的影响。在 2-3 个月龄时,与野生型对照组相比,hmα-SYN-39 小鼠黑质 (SN) 致密部多巴胺能神经元数量没有显著差异。然而,在 16-17 个月龄时,与年轻的 2-3 个月龄转基因小鼠和 16-17 个月龄野生型同窝小鼠相比,hmα-SYN-39 小鼠显示出明显的多巴胺能 SN 神经元丧失、纹状体多巴胺能末梢丧失以及纹状体多巴胺水平降低。在 hmα-SYN-39 小鼠中,发现浸润的 CD4 和 CD8 T 细胞数量与纹状体多巴胺能末梢丧失呈显著的年龄相关性,但在野生型对照组中没有发现。与年轻的同龄小鼠相比,在 16-17 个月龄野生型小鼠的纹状体中观察到 CD8 T 细胞计数和 CD11b 小胶质细胞计数略有升高。对野生型小鼠黑质纹状体神经炎症的进一步分析没有发现 CD4、CD8 T 细胞和 B220 B 细胞数量有任何显著的年龄依赖性变化。相比之下,在 hmα-SYN-39 小鼠的 SN 中观察到 CD8 T 细胞、GFAP 星形胶质细胞以及 CD11b 小胶质细胞数量的显著年龄依赖性增加,这表明在这种 PD 的遗传小鼠模型中存在神经炎症过程。hmα-SYN-39 小鼠模型的研究结果进一步证实了 T 细胞和神经胶质细胞反应参与了 PD 的年龄相关神经退行性变。在 hmα-SYN-39 PD 啮齿动物模型中,神经退行性变和神经炎症的缓慢和年龄依赖性进展强调了其转化价值,使其适合研究抗炎治疗。

相似文献

[1]
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease.

Neurobiol Dis. 2022-9

[2]
Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.

Brain Behav Immun. 2022-3

[3]
Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.

Int J Mol Sci. 2021-3-13

[4]
The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson's Disease.

Mol Neurobiol. 2024-9

[5]
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.

J Neuroinflammation. 2020-8-15

[6]
Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.

Glia. 2018-4-6

[7]
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.

J Neuroinflammation. 2022-12-31

[8]
Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

Environ Health Perspect. 2011-1-18

[9]
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.

Acta Pharmacol Sin. 2024-2

[10]
Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.

Proc Natl Acad Sci U S A. 2017-9-12

引用本文的文献

[1]
The role of T cells in the treatment of Parkinson's disease.

PeerJ. 2025-8-14

[2]
Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.

NeuroImmune Pharm Ther. 2025-6-20

[3]
A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap.

Alzheimers Dement. 2025-6

[4]
(Re)building the nervous system: A review of neuron-glia interactions from development to disease.

J Neurochem. 2025-1

[5]
α-Synuclein pathology as a target in neurodegenerative diseases.

Nat Rev Neurol. 2025-1

[6]
A framework for translational therapy development in deep brain stimulation.

NPJ Parkinsons Dis. 2024-11-8

[7]
Evidence for prodromal changes in neuronal excitability and neuroinflammation in the hippocampus in young alpha-synuclein (A30P) transgenic mice.

Front Dement. 2024-6-17

[8]
Time association study on a sub-acute mouse model of Parkinson's disease.

Heliyon. 2024-7-4

[9]
Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies.

Metabolites. 2024-6-22

[10]
The immune system in Parkinson's disease: what we know so far.

Brain. 2024-10-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索